NSI Equity Snapshot
CAPLIPOINT Weekly Equity Report
Caplin Point Laboratories Limited
What the company does
Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic formulations and branded products in India. The company provides tablets, capsules, injections, ophthalmic, liquid orals, softgel capsules, ointments, creams and gels, powder for injections, suppositories, ovules, pre-mix bag formulations, inhalers, and sprays and IV infusion. It also provides dry and syrups, lyophilized vials, prefilled syringes, emulsion injection, sachets, liquid injectables, topicals, pre-filled syringes, and pre-mix bags. Caplin Point Laboratories Limited was incorporated in 1990 and is headquartered in Chennai, India.
What the weekly tape is saying
CAPLIPOINT closed the latest completed week at 2,408 INR. The 4-week return is 20.7% and the 12-week return is 50.1%. Trend Signal is active, Market Dynamics is 1.50. Setup signature: Leadership continuation with a 78/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 1,827 INR
- Vs Trend Line
- 31.8%
- Fair Value
- 1,692 INR
- Vs Fair Value
- 42.3%
- 52W High
- 2,425 INR
- 52W Low
- 1,497 INR
- Drawdown
- -0.7%
- Range Position
- 98.1%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 1 weeks
- 52W Active Weeks
- 11
- 52W Active Breadth
- 21.2%
- Sector Scope
- IN Healthcare
- Sector Rank
- 5 of 161
- Sector Percentile
- 97.5%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
IN Healthcare
- Tracked Peers
- 100
- 4W Rank
- 14 of 100
- Avg 1W
- 2.2%
- Avg 4W
- 5.7%
- Trend Breadth
- 55.0%
- Positive MD
- 90.0%
IN Drug Manufacturers - Specialty & Generic
- Tracked Peers
- 92
- 4W Rank
- 15 of 92
- Avg 1W
- 2.0%
- Avg 4W
- 7.4%
- Trend Breadth
- 50.0%
- Positive RS
- 65.2%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 1.50
- 4W MD Change
- 40.7%
- Relative Strength
- 31.39
- 4W RS Change
- 242.2%
- Expectation
- Positive
- Probability
- 55.91%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 2.6M
- 13W Average
- 802.1K
- 52W Average
- 493.4K
- Vs 13W
- 3.3x
- Vs 52W
- 5.3x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 6.1%
- 52W Volatility
- 4.6%
- Upside Weeks
- 27
- Downside Weeks
- 25
- Downside Breadth
- 48.1%
- Avg Gain / Loss
- 3.3% / -2.9%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- NSI
- Country
- IN
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- INR
- Market Cap
- 153.9B
Opportunity signals
- Trend Signal is active with a 1-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Market Dynamics is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
Risk signals
- No major top-level risk cluster is currently dominant.
Watch next
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 2,408 INR | 18.4% | 1,827 INR | 1,692 INR | 1.50 | 31.39 | 2.6M | On |
| 5 Jun 2026 | 2,033 INR | 0.4% | 1,811 INR | 1,681 INR | 1.46 | 12.59 | 479.8K | Off |
| 29 May 2026 | 2,024 INR | 0.0% | 1,808 INR | 1,673 INR | 1.53 | 11.34 | 439.5K | Off |
| 22 May 2026 | 2,024 INR | 1.5% | 1,808 INR | 1,665 INR | 1.34 | 10.49 | 752.7K | Off |
| 15 May 2026 | 1,995 INR | 7.7% | 1,807 INR | 1,657 INR | 1.07 | 9.17 | 2.9M | Off |
| 8 May 2026 | 1,853 INR | 8.6% | 1,807 INR | 1,649 INR | 0.89 | -0.74 | 633.4K | Off |
| 1 May 2026 | 1,706 INR | -0.6% | 1,814 INR | 1,641 INR | 0.49 | -7.95 | 261.2K | Off |
| 24 Apr 2026 | 1,716 INR | -2.9% | 1,824 INR | 1,635 INR | -0.05 | -7.14 | 285.1K | Off |
| 17 Apr 2026 | 1,767 INR | 3.7% | 1,835 INR | 1,628 INR | -0.53 | -6.23 | 564.8K | Off |
| 10 Apr 2026 | 1,705 INR | 9.1% | 1,854 INR | 1,621 INR | -1.16 | -8.62 | 528.9K | Off |
| 3 Apr 2026 | 1,563 INR | 0.3% | 1,872 INR | 1,614 INR | -1.53 | -11.55 | 287.1K | Off |
| 27 Mar 2026 | 1,558 INR | -2.8% | 1,891 INR | 1,608 INR | -1.55 | -12.54 | 380.4K | Off |
| 20 Mar 2026 | 1,604 INR | -3.5% | 1,909 INR | 1,602 INR | -1.54 | -11.48 | 331.2K | Off |
| 13 Mar 2026 | 1,662 INR | -0.2% | 1,928 INR | 1,595 INR | -1.52 | -8.78 | 298.9K | Off |